These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3333409

  • 1. Efficacy of azathioprine versus cyclosporine on kidney graft survival in transfused and nontransfused unmatched mongrel dogs.
    Finco DR, Rawlings CA, Crowell WA, Brown SA, Barsanti JA.
    J Vet Intern Med; 1987; 1(2):61-6. PubMed ID: 3333409
    [Abstract] [Full Text] [Related]

  • 2. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE, Banowsky LH, Novick AC, Lewis RM, Streem SB, Steinmuller DR, Holzmann JJ, McFarlin L, Graneto DE.
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [Abstract] [Full Text] [Related]

  • 3. Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow.
    Mathews KA, Holmberg DL, Johnston K, Miller CM, Binnington AG, Maxie G, Atilola M, Smith G.
    Vet Surg; 1994 Mar; 23(5):347-57. PubMed ID: 7839592
    [Abstract] [Full Text] [Related]

  • 4. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
    Collier DS, Calne RY, De Curtins M, Thiru S, White DJ, Jamieson NV, Thick M, Barroso E.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC, Johnson K, Richie R, Nylander W, McMahon Y, Niblack G, Green W, Morrissey J, Ynares C.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion.
    Watanabe K, Yuge K, Sato K, Yamagishi K, Sonoda K, Masaki Y, Maruyama S, Takahara H, Matsubayashi T, Yago K.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1112-5. PubMed ID: 2468213
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR, Alexander SR, Melvin T, Striegel J, Reller K, Norman DJ, Barry JM.
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [Abstract] [Full Text] [Related]

  • 11. The role of blood transfusion in the age of cyclosporine.
    Perloff LJ.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):29-37. PubMed ID: 3515691
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M, Ramalho HJ, Barberato JB, Corrente JE, Zerati-Filho M, Verona CB, Martucci RC, Bezas AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
    Moyer TP, Post GR, Sterioff S, Anderson CF.
    Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporine on fresh and preserved orthotopic small bowel allografts.
    Toledo-Pereyra LH, Kaufmann RJ, Bergren CT.
    P R Health Sci J; 1987 Dec; 6(3):147-52. PubMed ID: 3438458
    [Abstract] [Full Text] [Related]

  • 15. Single-center analysis of impact of immunosuppressive therapy upon renal allograft survival in the black population.
    Van Buren DH, Richie RE, Nylander W, Helderman H, MacDonell RC, Johnson HK.
    South Med J; 1991 Jun; 84(6):715-8. PubMed ID: 2052958
    [Abstract] [Full Text] [Related]

  • 16. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract] [Full Text] [Related]

  • 17. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH, Hudson SL, Deierhoi MH, Laskow DA, Gaston RS, Julian BA, Curtis JJ, Diethelm AG.
    Clin Transpl; 1990 Jun; ():289-300. PubMed ID: 2103152
    [Abstract] [Full Text] [Related]

  • 18. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M, Barberato JB, Ramalho HJ, Saldanha LB, Casassanta DM, Denadai ER, Zerati S, Bezas AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression with cyclosporine. A new approach to improve patency of venous allografts.
    Bandlien KO, Toledo-Pereyra LH, MacKenzie GH, Choudhury SP, Cortez JA.
    Arch Surg; 1983 Jul; 118(7):829-33. PubMed ID: 6860131
    [Abstract] [Full Text] [Related]

  • 20. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS.
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.